Kidney aging: From phenotype to genetics

Rejuvenation Research

Volumn 8, Issue 2, 2005, Pages 101-109

  Buemi, Michele ^a,b   Nostro, Lorena ^a   Aloisi, Carmela ^a   Consentini, Vincenzo ^a   Criseo, Manila ^a   Frisina, Nicola ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

AGING; ATHEROSCLEROSIS; COMORBIDITY; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HEREDITY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

AGED; AGING; HUMANS; KIDNEY; KIDNEY FAILURE; PHENOTYPE;

EID: 20544438869     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2005.8.101     Document Type: Review

References (62)

1. Vrtovsnik F, Porcher R, Michel C, Hufnagel G, Queffeulou G, Mentre F, Mignon F. Survival of elderly patients on peritoneal dialysis: retrospective study of 292 patients, from 1982 to 1999. Perit Dial Int 2002; 22:73-81.
2. USRDS. Incidence and prevalence of ESRDS. Annual Data Report, 1999.
3. Valderrabano F, Jones EH, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995;10:1-25.
4. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe FLA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000;35:157-165.
5. Gourtsoyiannis N, Prassopoulos P, Cavouras D, Pantelidis N. The thickness of the renal parenchyma decreases with age. A CT study of 360 patients. Am J Roentgenol 1990;155:541-544.
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16: 31-41.
7. Levey AS, Bosch JP, Lewis JB. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
8. Linderman RD, Tobin J, Shock NW Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278-285.
9. Tauchi H, Tsuboi K, Okutomi J. Age changes in the human kidney of the different races. Gerontologia 1971;17:87-97.
10. Kaplan C, Pasternack B, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975;80:234.
11. Tracy RE, Parra D, Eisaguirre W, Torres Baldanza A. Influence of arteriolar hyalinization on arterial intimal fibroplasia in the renal cortex of subjects in the United States, Peru, and Bolivia, applicable also to other populations. Am J Hypertens 2002;15:1064-1073.
12. Takazakura E, Sawabu N, Handa A, Takada A, Shinoda A, Takeuchi J. Intrarenal vascular changes with age and disease. Kidney Int 1972;2:224-230.
13. Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 1998;9:231-242.
14. Yukawa K, Kishino M, Goda M, Liang XM, Kimura A, Tanaka T, Bai T, Owada-Makabe K, Tsubota Y, Ueyama T, Ichinose M, Maeda M, Takeda K, Akira S. STAT6 deficiency inhibits tubulointerstitial fibrosis in obstructive nephropathy. Int J Mol Med 2005;15: 225-230.
15. Wang S, Wilkes MC, Leof EB, Hirschberg R. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. FASEB J 2005; 19:1-11.
16. Price RJ, Lee JS, Skalak TC. Microvascular volume contribution to hemorrage compensation. Am J Physiol 1993;264:2085-2093.
17. Murata K, Horiuchi Y. Age-dependent distribution of acidic glycosaminoglycans in human kidney tissue. Nephron 1978;20:111-118.
18. Plante GE. Impact of aging on the body's vascular system. Metabolism 2003;52:31-35.
19. Halloran PF, Melk A. Sénescence rénale, sénescence cellulaire et leur role en néphrologie et transplantation. In: Mèdecine-Sciences-Flammarion, ed. Actualités Né phrologiques. Paris: Jean Hamburger. 2001: 249-258.
20. Thomson SC, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004;286: F8-F15.
21. Cullen-McEwen LA, Kett MM, Dowling J, Anderson WP, Bertram JF. Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice. Hypertension 2003;41:335.
22. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985;249:F324-F337.
23. Zatz R, Meyer TW, Rennke HG, Brenner BM. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985;82:5963-5867.
24. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985;76:612-619.
25. Inserra F, Stella I, Kurnek ML. Losartan and enalapril protect against age-related kidney lesions in normal rats treated from 12 to 18 months of age. J Am Soc Nephrol 2001;12:679A.
26. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med 2003 9;348:101-108.
27. Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997;51:1196-1204.
28. Lindeman RD, Tobin J, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int 1984;26:861-868.
29. Schmieder RE, Schächinger H, Messerli FH. Accelerated decline in renal perfusion with aging in essential hypertension. Hypertension 1994;23:351-357.
30. Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987;31:1153-1159.
31. Bax L, van der Graaf Y, Rabelink AJ, Algra A, Beutler JJ, Mali WP, for the SMART Study Group. Influence of atherosclerosis on age-related changes in renal size and function. Eur J Clin Invest 2003;33:34-40.
32. Reckelhoff JF, Kellum JA Jr, Racusen LC, Hildebrandt DA. Long-term dietary supplementation with L-arginine prevents age-related reduction in renal function. Am J Physiol 1997;272:R1768-R1774.
33. Kielstein JT, Bode-Boger SM, Haller H, Fliser D. Functional changes in the ageing kidney: is there a role for asymmetric dimethylarginine? Nephrol Dial Transplant 2003;18:1245-1248.
34. Adler S, Huang H, Wolin MS, Kaminski PM. Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney. J Am Soc Nephrol 2004;15:3-11.
35. Song X, Bao M, Li D, Li YM. Advanced glycation in D-galactose-induced mouse aging model. Mech Ageing Dev 1999;108:239-251.
36. nd, Salahudeen AK. Vitamin E ameliorates enhanced renal lipid peroxidation and accumulation of F2-isoprostanes in aging kidneys. Am J Physiol 1998;274:R76-R74.
37. Zou AP, Cowley AW Jr. Reactive oxygen species and molecular regulation of renal oxygenation. Acta Physiol Scand 2003;179:233-241.
38. Buemi M, Aloisi C, Cavallaro E, Corica F, Floccari F, Grasso G, Lasco A, Pettinato G, Ruello A, Sturiale A, Frisina N. Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia. J Nephrol 2002;15:97-103.
39. Frenkel-Denkberg G, Gershon D, Levy AP. The function of hypoxia-inducible factor 1 (HIF-1) is impaired in senescent mice. FEBS Lett 1999;462:341-344.
40. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25:585-621.
41. Melk A, Ramassar V, Helms LM, Moore R, Rayner D, Solez K, Halloran PF. Telomere shortening in kidney with age. J Am Soc Nephrol 2000;11:444-453.
42. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996;16:859-867.
43. Melk A, Turner P, Helms LM. Expression of senescence regulator P16INK4a mRNA in some human kidney samples. J Am Soc Nephrol 2000;11:461A.
44. Melk A, Schmidt BM, Takeuchi O, Sawitzki B, Rayner DC, Halloran PF. Expression of p16INK4a and other cell cycle regulator and senescence-associated genes in aging human kidney. Kidney Int 2004;65:510-520.
45. Terasaki PI, Cecka JM, Gjertson DW. Impact analysis: a method for evaluating the impact of factors in clinical renal transplantation. Clin Transpl 1998;437-441.
46. Andreassi MG, Botto N. DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med 2003;13:270-275.
47. Joosten SA, van Ham V, Nolan CE, Borrias MC, Jardine AG, Shiels PG, Kooten CV, Paul LC. Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am J Pathol 2003;162: 1305-1312.
48. Andres A, Casal C, Vereda S, Vazquez S, Cebrian MP, Nuno E, Delgado I, Herrero JC, Morales JM, Rodicio JL, Praga M, Diaz R, Leiva O. Double (dual) renal transplants for elderly recipients, using elderly cadaveric donors. Dial Transplant 2003;32:499-513.
49. Morrissey PE, Gohh R, Yango A, Gautam A, Monaco AP. Renal transplant survival from older donors: a single center experience. Arch Surg 2004;139:384-389.
50. Oniscu GC, Brown H, Forsythe JL. How great is the survival advantage of transplantation over dialysis in elderly patients? Nephrol Dial Transplant 2004;19: 945-951.
51. Bertoni E, Rosati A, Zanazzi M, Di Maria L, Becherelli P, Gallo M, Salvadori M. Excellent outcome of renal transplantation using single old kidneys in old recipients. Ann Transplant 2004;9:25-26.
52. Inserra F, Romano L, Cavanagh EMV, de Ercole L, Ferder L, Gomez R. Renal interstitial sclerosis in aging: effects of enalapril and nifedipine. J Am Soc Nephrol 1996;7:676-680.
53. Ferder L, Inserra F, Romano L, Ercole L, Pszenny V. Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors. J Am Soc Nephrol 1994;5:1147-1152.
54. Ferder L, Inserra F, Basso N. Effects of renin angiotensin system blockade in the aging kidney. Exp Gerontol 2003;38:237-244.
55. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima Y. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997;390:45-51.
56. Takahashi Y, Kuro-o M, Ishikawa F. Aging mechanisms. Proc Nat Acad Sci USA 2000;97:12407-12408.
57. Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 1998;242:626-630.
58. Yahata K, Mori K, Arai H, Koide S, Ogawa Y, Mukoyama M, Sugawara A, Ozaki S, Tanaka I, Nabeshima Y, Nakao K. Molecular cloning and expression of a novel klotho-related protein. J Mol Med 2000;78:389-394.
59. Nagai R, Saito Y, Ohyama Y, Aizawa H, Suga T, Nakamura T, Kurabayashi M, Kuro-o M. Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 2000;57:738-746.
60. Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T, Sugimura K, Kishimoto T, Kinoshita S, Kuroki T, Nabeshima Y. Severely reduced production of Klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 2001;280:1015-1020.
61. Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, Amaki T, Mori I, Nakamura Y, Sato M, Nangaku M, Hirata Y, Nagai R. In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension 2002;39:838.
62. Saito K, Ishizaka N, Mitani H, Ohno M, Nagai R. Iron chelation and free radical scavenger suppress angiotensin II-induced downregulation of klotho, an anti-aging gene, in rat. FEBS Lett 2003;551:58-62.